Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.
Anal Methods. 2021 Jul 29;13(29):3264-3273. doi: 10.1039/d1ay00525a.
A novel extraction technique i.e. hydrophobic magnetic nanoparticle (MNP)-assisted in situ supramolecular solvent (SUPRAS) microextraction was proposed, and it was applied for the analysis of sulfonamides (SAs) and fluoroquinolones (FQs) in aqueous samples, coupled with high performance liquid chromatography-UV detection (HPLC-UV). In this extraction method, hexafluoroisopropanol-mediated salt-free catanionic surfactant based SUPRAS in situ microextraction was initially carried out; then, the SUPRAS was quickly adsorbed by the hydrophobic magnetic nanoparticles and gathered by an external magnetic field. This can greatly shorten the separation time and overcome the dependence on centrifugation, and also perform a secondary extraction of free analytes (not extracted by SUPRAS) from water samples. The magnetic separation ability of different hydrophobic MNPs was evaluated by adsorbing supramolecular aggregates from the water sample. The effective parameters affecting the extraction efficiency of the analytes were investigated and optimized using the one variable at a time method. About 3 min was required to realize the extraction of analytes with an enrichment factor (EF) of 12-53 for SAs and 79-118 for FQs. Compared with the centrifugation-assisted SUPRAS microextraction, the hydrophobic MNP-assisted SUPRAS microextraction obtained much better extraction and preconcentration efficiency. The proposed novel extraction method with HPLC-UV provided LODs of 0.21-0.76 ng mL-1 for SAs and 0.10-0.18 ng mL-1 for FQs. Good linearity was obtained with correlation coefficients ranging from 0.9962 to 0.9999. The intra- and inter-day recoveries of the target antibiotics were in the range of 92.0-111.3% with RSD% below 10.4%. The method was successfully applied to determine SAs and FQs in real water samples, such as lake water, river water, reservoir water, and wastewater.
提出了一种新型的萃取技术,即疏水性磁性纳米粒子(MNP)辅助原位超分子溶剂(SUPRAS)微萃取,并将其应用于水溶液中磺胺类(SAs)和氟喹诺酮类(FQs)的分析,与高效液相色谱-紫外检测(HPLC-UV)联用。在这种萃取方法中,首先进行了六氟异丙醇介导的盐自由两性离子表面活性剂 SUPRAS 原位微萃取;然后,SUPRAS 被疏水性磁性纳米粒子迅速吸附,并在外磁场的作用下聚集。这可以大大缩短分离时间,克服对离心的依赖,并从水样中二次萃取游离分析物(未被 SUPRAS 萃取的)。通过从水样中吸附超分子聚集体来评估不同疏水性 MNPs 的磁分离能力。使用单变量法研究并优化了影响分析物萃取效率的有效参数。实现分析物的萃取大约需要 3 分钟,磺胺类的富集因子(EF)为 12-53,氟喹诺酮类的 EF 为 79-118。与离心辅助 SUPRAS 微萃取相比,疏水性 MNP 辅助 SUPRAS 微萃取获得了更好的萃取和预浓缩效率。该新型萃取方法与 HPLC-UV 联用,磺胺类的检出限为 0.21-0.76ngmL-1,氟喹诺酮类的检出限为 0.10-0.18ngmL-1。线性相关系数范围为 0.9962-0.9999。目标抗生素的日内和日间回收率在 92.0%-111.3%之间,相对标准偏差(RSD%)低于 10.4%。该方法成功应用于实际水样中磺胺类和氟喹诺酮类的测定,如湖水、河水、水库水和废水。